Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354873 · ClinicalTrials.gov registry record
Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 556
- Enrollment target
NCT01354873: Completed study, sponsored by Mayo Clinic.
NCT01354873 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 556 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01354873 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 556 participants
- Enrollment target
Study Summary
The investigators seek to compare the accuracy of the existing colonoscope model to determine the magnitude of the improvement the investigators can expect in polyp discrimination as neoplastic or non-neoplastic.
Primary Outcome
Compare accuracy of current colonoscope to improved colonoscope for discrimination of polyps as neoplastic versus non-neoplastic. The accuracies of the two approaches will be compared via logistic regression model with the significance of the difference in the accuracies assessed via generalized estimating equation approach to take account of the possible dependence introduced by inclusion of mulitple polyps per patient.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 556 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-08 |
What the finished NCT01354873 record still lists
NCT01354873 is an observational study that tracks outcomes without assigning an intervention. The registered 556 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01354873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01354873 about?
NCT01354873 is a clinical study titled "Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging". The investigators seek to compare the accuracy of the existing colonoscope model to determine the magnitude of the improvement the investigators can expect in polyp discrimination as neoplastic or non-neoplastic.
What is the current status of trial NCT01354873?
This trial is currently completed. The enrollment target is 556 participants. The study started on 2011-01. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01354873?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT06799000 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia